Adverts

Open Access Articles- Top Results for Mozavaptan

Mozavaptan

</th></tr>
Mozavaptan
File:Mozavaptan structure.svg
Systematic (IUPAC) name
N-[4-(5-Dimethylamino-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)phenyl]-2-methylbenzamide
Clinical data
  • (Prescription only)
Oral
Identifiers
137975-06-5 7pxN
None
PubChem CID 119369
ChemSpider 106618 7pxY
UNII 17OJ42922Y 7pxY
ChEMBL CHEMBL420762 7pxY
Chemical data
Formula C27H29N3O2
427.53 g/mol
 14pxN (what is this?)  (verify)

Mozavaptan (INN) is a vasopressin receptor antagonist marketed by Otsuka. In Japan, it was approved in October 2006 for hyponatremia (low blood sodium levels) caused by syndrome of inappropriate antidiuretic hormone (SIADH) due to ADH producing tumors.

References


Lua error in package.lua at line 80: module 'Module:Buffer' not found.